SecBot SecBot
Insider Cluster (2 insiders) ·Filed Mar 4, 2026

WGS

GeneDx Holdings Corp.
NEUTRAL
Impact 4/10
Horizondays Processed8mo ago
Insider cluster: 2 insiders, $566K total
Actionable Insight • Neutral

Monitor for any follow-up filings or commentary around executive sentiment; current activity is within normal ranges and not materially bearish given the company's size.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$79.47
T+0 close · Mar 3, 2026 · via day close
Latest settled
−36.89%
T+60 · $50.15
Vs SPY
−46.98%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 4 $79.47entry
  2. T+1 · 9mo ago +3.18%α +3.76% · $82.00
  3. T+5 · 8mo ago +7.08%α +8.42% · $85.10
  4. T+20 · 8mo ago −17.55%α −13.14% · $65.52
  5. T+60 · 6mo ago −36.89%α −46.98% · $50.15
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

GeneDx CEO and CFO conducted open-market share sales totaling $587,754 over four days, while also receiving non-cash stock awards and exercising options. The sales represent a routine level of insider activity relative to the company's $2.3B market cap.

Key Financial Metrics

Direction
selling
Total Value
$587.8K
Insiders
2

Key Facts

  • CEO Katherine Stueland sold 5,861 shares for $454,967 in an open-market transaction.
  • CFO Kevin Feeley sold a total of 1,711 shares across two transactions for $132,787.
  • Total open-market sales by insiders in the cluster amount to $587,754 over seven days.
  • CEO and CFO also received stock awards totaling 62,946 shares with no cash value (non-cash events).
  • CFO exercised 718 shares via derivative, a non-cash transaction.

Financial Impact

$587,754 in net open-market selling by C-suite executives

insider ownershipshare count

Risk Factors

  • Perception risk from concentrated C-suite selling, despite being routine in magnitude.
  • Potential misinterpretation of non-cash awards as insider buying, these are standard compensation grants.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (6 trades, 7d window)cluster-WGS-1772751291167

Track record

13 reports on WGS

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +63.51% at T+60 after the May 20, 2026 report. 7 of 7 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $52.37 Now $51.02 −2.58% settles Feb 11
  2. Nov 9, 20267d ago 8-K Bullish 6/10 Entry $54.83 Now $51.02 −6.95% settles Feb 8
  3. Nov 6, 202610d ago SC 13G Neutral 3/10 Entry $62.37 Now $51.02 −18.20% settles Feb 4
  4. Sep 18, 20268w ago Insider Cluster Bearish 4/10 Entry $97.83 Now $51.02 +47.85% settles Dec 15
  5. Sep 11, 20269w ago Insider Cluster Neutral 2/10 Entry $89.74 Now $51.02 −43.15% settles Dec 8
  6. Sep 1, 202610w ago 144 Neutral 2/10 Entry $86.72 Now $51.02 −41.17% settles Nov 27
  7. Jun 16, 202621w ago 8-K Neutral 3/10 Entry $60.60 to $83.96 Now $51.02 −15.81% ▲ +38.55% +37.55% vs SPY
  8. Jun 11, 202622w ago Institutional Cluster Bullish 4/10 Entry $59.92 to $85.87 Now $51.02 −14.85% ▲ +43.31% +40.04% vs SPY
  9. Jun 8, 202623w ago Insider Cluster Bullish 6/10 Entry $56.33 to $86.72 Now $51.02 −9.43% ▲ +53.95% +50.14% vs SPY
  10. May 20, 202625w ago Insider Cluster Bullish 6/10 Entry $47.33 to $77.39 Now $51.02 +7.80% ▲ +63.51% +59.21% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens Wed (10h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 5, 2026